Antibiotic Treatment for Impetigo
For impetigo treatment, topical mupirocin 2% ointment is the first-line therapy for limited disease, while oral antibiotics such as dicloxacillin, cephalexin, or clindamycin are recommended for extensive disease, with clindamycin being preferred when MRSA is suspected. 1, 2
Types of Impetigo and Causative Organisms
Impetigo presents in two main forms:
- Nonbullous impetigo (70% of cases): Caused by Staphylococcus aureus or Streptococcus pyogenes
- Bullous impetigo (30% of cases): Caused exclusively by S. aureus 1, 3
Treatment Algorithm
1. Limited Disease (Few Lesions)
- First-line: Topical mupirocin 2% ointment applied three times daily for 7 days 1, 2
- Highly effective against both S. aureus and S. pyogenes
- FDA-approved specifically for impetigo treatment 2
- Alternatives:
- Retapamulin
- Fusidic acid (not available in all countries) 1
2. Extensive Disease (Multiple Lesions or Widespread)
- For MSSA infections:
- Dicloxacillin or cephalexin for 7 days 1
- For confirmed streptococcal infections:
- Oral penicillin for 7 days 1
- For suspected or confirmed MRSA:
- Clindamycin 300mg three times daily for 7-10 days 1
- Provides excellent coverage against both MRSA and streptococci
3. Treatment Duration
- Standard duration: 7 days for oral antibiotics
- Evaluate clinical response within 48-72 hours 1
- Expected resolution within 7-10 days of starting appropriate treatment 1
Evidence-Based Comparisons
- Topical vs. Oral: Topical mupirocin has shown similar or superior efficacy to oral erythromycin in clinical trials 4, 5
- Side Effects: Oral antibiotics cause more side effects, particularly gastrointestinal issues, compared to topical treatments 5
- Resistance Concerns:
Important Clinical Considerations
- MRSA Awareness: Community-acquired MRSA (CA-MRSA) is an increasing concern as an etiological agent 1
- Culture Indications: Consider bacterial culture and sensitivity testing if no improvement after 3-5 days 1
- Pediatric Considerations: Avoid tetracyclines (doxycycline, minocycline) in children under 8 years due to risk of inhibiting bone growth 1
Common Pitfalls to Avoid
- Failing to consider MRSA in recalcitrant cases
- Using penicillin as first-line therapy (inferior efficacy)
- Inadequate duration of therapy
- Relying solely on topical therapy for extensive disease
- Using topical disinfectants (inferior to antibiotics) 1, 6
- Using TMP-SMX for streptococcal impetigo (inadequate coverage) 1, 3
Prevention Measures
- Keep lesions covered when possible
- Use separate towels and linens
- Practice good hand hygiene
- Prompt identification and treatment of cases 1